365 related articles for article (PubMed ID: 20810669)
41. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
[TBL] [Abstract][Full Text] [Related]
42. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
43. Effects of different doses of metformin treatment for 6 months on aberrant crypt foci in Chinese patients with impaired glucose tolerance.
Zhao X; Li Y; Chen M; Chen Y; Dai Y; Wang Y; Xie H
Eur J Cancer Prev; 2015 Jan; 24(1):27-36. PubMed ID: 25162967
[TBL] [Abstract][Full Text] [Related]
44. Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.
Imchen T; Manasse J; Min KW; Baek SJ
Exp Toxicol Pathol; 2013 Sep; 65(6):919-24. PubMed ID: 23369238
[TBL] [Abstract][Full Text] [Related]
45. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
[TBL] [Abstract][Full Text] [Related]
46. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
[TBL] [Abstract][Full Text] [Related]
47. L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma.
Ma Q; Wang Y; Gao X; Ma Z; Song Z
Clin Cancer Res; 2007 Dec; 13(24):7407-12. PubMed ID: 18094424
[TBL] [Abstract][Full Text] [Related]
48. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
49. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis.
Hurlstone DP; Cross SS
J Gastroenterol Hepatol; 2005 Feb; 20(2):173-81. PubMed ID: 15683417
[TBL] [Abstract][Full Text] [Related]
50. Classification of aberrant crypt foci and microadenomas in human colon.
Roncucci L; Medline A; Bruce WR
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):57-60. PubMed ID: 1845171
[TBL] [Abstract][Full Text] [Related]
51. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
52. [Effects of tea on aberrant crypt foci and colorectal tumors in rats].
Jia X; Wang W; Cui W; Han C
Wei Sheng Yan Jiu; 2000 Jan; 29(1):54-6. PubMed ID: 12725046
[TBL] [Abstract][Full Text] [Related]
53. Biology and diagnosis of aberrant crypt foci.
Lopez-Ceron M; Pellise M
Colorectal Dis; 2012 Apr; 14(4):e157-64. PubMed ID: 22182185
[TBL] [Abstract][Full Text] [Related]
54. Protective effect of metformin in an aberrant crypt foci model induced by 1,2-dimethylhydrazine: Modulation of oxidative stress and inflammatory process.
Bordini HP; Kremer JL; Fagundes TR; Melo GP; Conchon-Costa I; da Silva SS; Cecchini AL; Panis C; Luiz RC
Mol Carcinog; 2017 Mar; 56(3):913-922. PubMed ID: 27585117
[TBL] [Abstract][Full Text] [Related]
55. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
[TBL] [Abstract][Full Text] [Related]
56. Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial.
Higurashi T; Takahashi H; Endo H; Hosono K; Yamada E; Ohkubo H; Sakai E; Uchiyama T; Hata Y; Fujisawa N; Uchiyama S; Ezuka A; Nagase H; Kessoku T; Matsuhashi N; Yamanaka S; Inayama Y; Morita S; Nakajima A
BMC Cancer; 2012 Mar; 12():118. PubMed ID: 22443173
[TBL] [Abstract][Full Text] [Related]
57. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
[TBL] [Abstract][Full Text] [Related]
58. Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.
Limburg PJ; Mahoney MR; Ziegler KL; Sontag SJ; Schoen RE; Benya R; Lawson MJ; Weinberg DS; Stoffel E; Chiorean M; Heigh R; Levine J; Della'Zanna G; Rodriguez L; Richmond E; Gostout C; Mandrekar SJ; Smyrk TC;
Cancer Prev Res (Phila); 2011 Feb; 4(2):259-69. PubMed ID: 21209397
[TBL] [Abstract][Full Text] [Related]
59. Combined use of vitamin D3 and metformin exhibits synergistic chemopreventive effects on colorectal neoplasia in rats and mice.
Li W; Wang QL; Liu X; Dong SH; Li HX; Li CY; Guo LS; Gao JM; Berger NA; Li L; Ma L; Wu YJ
Cancer Prev Res (Phila); 2015 Feb; 8(2):139-48. PubMed ID: 25416412
[TBL] [Abstract][Full Text] [Related]
60. Dietary aloe vera gel powder and extract inhibit azoxymethane- induced colorectal aberrant crypt foci in mice fed a high- fat diet.
Chihara T; Shimpo K; Kaneko T; Beppu H; Higashiguchi T; Sonoda S; Tanaka M; Yamada M; Abe F
Asian Pac J Cancer Prev; 2015; 16(2):683-7. PubMed ID: 25684508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]